Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers

NCT03956134 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Tapentadol Test Product 1
DRUG: Tapentadol Test Product 2
DRUG: Tapentadol Prolonged-release Reference Product

Sponsor

Grünenthal GmbH